ADHD

The Pharmacy Times® Attention-Deficit Hyperactivity Disorder (ADHD) Resource Center is a comprehensive resource for clinical news and expert insights on issues related to ADHD, a chronic condition that can cause attention difficulty, hyperactivity, and impulsiveness.

Viloxazine ER Shows Promising Outcomes for Adult Patients with ADHD

September 06, 2022

Article

Viloxazine ER treatment was associated with symptom, function, and clinical improvement in adults with attention-deficit hyperactivity disorder.

Digital Therapeutics Show Promise, But Payer Uptake Remains Slow

May 03, 2022

Article

Digital medicine is the use of technology to measure or intervene in certain health conditions and is overseen by the FDA, unlike digital health apps or technologies.

FDA Approves Viloxazine Extended-Release Capsules for ADHD

May 02, 2022

Article

Viloxazine extended-release capsules are indicated as a once-daily, flexible-dose nonstimulant drug for attention-deficit hyperactivity disorder.

40% of Adults With ADHD Have Excellent Mental Health, Study Results Show

April 13, 2022

Article

Analysis indicates that factors associated with psychological flourishing include being married and physically active, as well as free from chronic pain and anxiety and depression.

Pharmacy Clinical Pearl of the Day: Adult Attention-Deficit Hyperactivity Disorder

November 25, 2021

Article

ADHD is a mental health disorder that includes a combination of persistent challenges, such as difficulty paying attention, hyperactivity, and impulsive behavior.

FDA Approves Once-Daily Tablets for Attention-Deficit Hyperactivity Disorder

November 05, 2021

Article

In a clinical study of healthy adults, Dyanavel XR tablets were deemed to be bioequivalent to amphetamine extended-release oral suspension in patients with ADHD.

A Pharmacist’s Personal Experience: Breaking Down Stigma to Improve Outcomes in ADHD

October 18, 2021

Article

Misconceptions about the diagnosis of attention-deficit hyperactivity disorder reduce the credibility of health care providers and delay or prevent treatment for patients suffering from this condition.

Pharmacy Quiz: Test Your Knowledge on ADHD

October 14, 2021

Article

Quiz questions to assess your knowledge on common symptoms and treatments for attention-deficit hyperactivity disorder.

ADHD Awareness Month and the Pharmacist’s Role

October 05, 2021

Article

ADHD Awareness Months brings attention to a common, but still somewhat misunderstood condition that pharmacists encounter on a near daily basis.

ADHD Is Not Likely to Go Away

September 15, 2021

Article

But the good news is treatments can be tailored for patients with the chronic behavioral condition.